V

Voyager Therapeutics

D
VYGR
USD
0.035
(0.4937%)
Market Closed
7,912.00
Volume
-1.17
EPS
-
Div Yield
26.389
P/E
388,549,434.75
Market Cap
Today
0.4937%
1 Week
1.496%
1 Month
0.494%
6 Months
-16.764%
12 Months
4.934%
Year To Date
-15.581%
All Time
0%

Title:
Voyager Therapeutics

Sector:
Healthcare
Industry:
Biotechnology
Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.
Do you need help or have a question?